Behind the scenes of psychedelic trials: Participant's perspective

Written By Guest User

Voices from the front lines, founder of PsyPAN, Psychedelic Participant Action Network, Ian Rollier is interviewed by EURACTIVE on the transformative process of the innovative mental health treatments, therapeutic value and the effects of psilocybin on depression.

Guest User
Previous

PAREA presents at MAPS Psychedelic Science
Next

First EU-wide Mental Health Initiative